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Abstract
Background: Myomectomy at time of cesarean delivery is traditionally discouraged because of the
risk of hemorrhage. A retrospective cohort study was performed to determine whether
myomectomy at time of cesarean delivery leads to an increased incidence of intrapartum and short-
term postpartum complications.
Methods: A computer search of medical records from May 1991 to April 2001 identified a total
of 111 women who underwent myomectomy at time of cesarean delivery and 257 women with
documented fibroids during the index pregnancy who underwent cesarean delivery alone. Charts
were reviewed for the following outcome variables: change in hematocrit from preoperative to
postoperative period, length of operation, length of postpartum stay, incidence of postpartum
fever, and incidence of hemorrhage. Hemorrhage was defined as a change in hematocrit of 10
points or the need for intraoperative blood transfusion.
Results: The incidence of hemorrhage in the study group was 12.6% as compared with 12.8% in
the control group (p = 0.95). There was also no statistically significant increase in the incidence of
postpartum fever, operating time, and length of postpartum stay. No patient in either group
required hysterectomy or embolization. Size of fibroid did not appear to affect the incidence of
hemorrhage. After stratifying the procedures by type of fibroid removed, intramural myomectomy
was found to be associated with a 21.2% incidence of hemorrhage compared with 12.8% in the
control group, but this difference was not statistically significant (p = 0.08). This study had 80%
power to detect a two-fold increase in the overall incidence of hemorrhage.
Conclusion: In selected patients, myomectomy during cesarean delivery does not appear to result
in an increased risk of intrapartum or short-term postpartum morbidity.
Background
Myomectomy at time of cesarean delivery has tradition-
ally been discouraged. With the exception of small,
pedunculated fibroids, most of the leading obstetrics text-
books advise against myomectomy during cesarean deliv-
ery due to theoretical risks of intractable hemorrhage and
increased postoperative morbidity. [1,2] In the medical
literature, however, there are few studies which directly
address this controversy. In fact, this recommendation
relies entirely on a body of evidence consisting of case
series and anecdotes which give conflicting results. [3-8]
In an attempt to define the risks of myomectomy during
cesarean delivery, we looked at our ten year experience at
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our institution with the procedure. Our objectives were
two-fold: to determine whether myomectomy at time of
cesarean delivery leads to an increased incidence of hem-
orrhage and perioperative morbidity; and to identify sub-
groups which may be at higher risk of developing
intrapartum hemorrhage.
Methods
A retrospective cohort design was used. A computer search
of hospital records at UCLA Medical Center and UCLA-
Santa Monica Medical Center was performed using the
diagnosis code for fibroids and procedure code for cesar-
ean delivery. This process identified 368 women with doc-
umented fibroids who underwent cesarean delivery with
or without myomectomy between May 1991 and April
2001. These women fulfilled the following criteria: (1)
documented fibroid uterus during the index pregnancy by
antepartum ultrasound or by intraoperative findings; (2)
delivery by cesarean delivery; (3) admission and postpar-
tum hematocrits in the database; (4) no evidence of ante-
natal bleeding (e.g., from placenta previa or abruption);
(5) no other procedures at the time of cesarean delivery
besides myomectomy (e.g., cystectomy, myolysis, or
planned hysterectomy); (5) no co-morbid conditions
with evidence of coagulopathy. The study group consisted
of patients who underwent myomectomy at time of cesar-
ean delivery; the control group consisted of patients with
documented fibroids during the index pregnancy who
underwent cesarean delivery alone.
Characteristics abstracted include age, parity, gestational
age at delivery, type of cesarean performed, and size and
location of fibroid. For the patients who underwent myo-
mectomy, the size of the excised fibroid was obtained
from the pathology report or, if no pathology report was
available, the surgeon's findings in the operative note. For
the control group, the size of fibroid was obtained from
the operative note or, if not indicated in the operative
note, from an antenatal ultrasound performed during that
pregnancy.
Primary outcomes analyzed were change in hematocrit,
postpartum fever, operative time, and length of postoper-
ative hospital stay. Hemorrhage was defined as a decrease
in hematocrit of 10 points from the preoperative value to
the postoperative value or the need for intraoperative
transfusion. Operative time was calculated from skin inci-
sion to skin closure as indicated in nursing notes. Fever
was defined as postoperative temperature greater than or
equal to 38.0°C.
All data was analyzed using Pearson's X2 or Fisher Exact
test for categorical variables and Student t-test for contin-
uous variables. The threshold of significance was defined
as p < 0.05.
Results
During the study period, 111 women underwent myo-
mectomy/cesarean delivery and 257 women with docu-
mented fibroids during the index pregnancy underwent
cesarean delivery alone. Demographic characteristics of
the control group and the study group are shown in Table
1. They were similar with respect to median age, median
parity, median gestational age, and median size of fibroid.
Most patients in both groups underwent low transverse
cesarean delivery.
The types of fibroid removed from the patients who
underwent myomectomy during cesarean delivery are
shown in Table 2. Of the women who underwent myo-
mectomy, the indication for the procedure in 86% of
patients was either not noted or was identified as inciden-
tal. Fourteen percent of patients had specific indications
documented including symptoms such as pain during
pregnancy, obstructed lower uterine segment, and unu-
sual intraoperative appearance.
The results of the primary outcomes are shown in Table 3.
The incidence of hemorrhage was 12.6% in the
myomectomy group and 12.8% in the control group (p =
0.95). One patient in the study group required postpar-
tum blood transfusion (0.9%) due to symptomatic ane-
mia and three patients in control group required blood
transfusion (1.2%), one intraoperatively and two postpar-
tum. In the myomectomy group, the mean change in
hematocrit was 5.5%, and 13 of 111 patients in this group
had a change in hematocrit of more than 10%. In the con-
trol group, the mean change in hematocrit was 6.1%, and
30 of 257 patients in this group had a change in hemat-
ocrit of more than 10%. No patient in either group
required hysterectomy or embolization within 6 weeks of
delivery. There was also no significant difference in the
incidence of fever, mean operative time, or mean length of
hospital stay. A power analysis reveals that, with this sam-
ple size, this study had the power to detect a two-fold
increase in incidence of hemorrhage from the control
group to the myomectomy group.
Results stratified by the size of fibroid removed is shown
in Table 4. No significant difference in the incidence of
hemorrhage for each size group. When stratifying results
by type of cesarean delivery performed, type of fibroid
removed (i.e., subserosal, intramural, submucosal, or
pedunculated), and location of fibroid removed, there
was no statistically significant difference in the incidence
of hemorrhage and other outcomes. But, of the 33
patients who underwent intramural myomectomy, 21.2%
of these patients met the criteria for hemorrhage com-
pared with 12.8% of control patients with documented
intramural fibroids, an increase that did not reach statisti-
cal significance (p = 0.08).BMC Pregnancy and Childbirth 2004, 4:14 http://www.biomedcentral.com/1471-2393/4/14
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Table 1: Population Characteristics
All Myomectomies All Controls
Number of patients 111 257
Median age in years (range) 37 (23–48) 35 (17–48)
Median parity (range) 0 (0–4) 0 (0–4)
Median gestational age in weeks (range) 38.0 (27.3–41.6) 39.1 (24–42.6)
Median size of fibroid in cm (range) 3.5 (0.9–30) 3 (1–20)
Type of cesarean section in number of patients:
Low transverse 105 250
Classical 67
Number of different primary surgeons 22 58
Table 2: Type of fibroid removed
Number of procedures (N = 111)
Submucosal 6 (5%)
Intramural 27 (24%)
Subserosal 27 (24%)
Pedunculated 25 (23%)
Multiple sites 20 (18%)
Not recorded 6 (5%)
Table 3: Outcomes of all cesarean myomectomy patients compared with controls
Myomectomy (N = 111) Controls (N = 257) p-value
Mean change in Hct, (range) 5.5 (-1.1 – 15) 6.1 (-3.3 – 18.3) NS
Incidence of hemorrhage 12.6% 12.8% NS
Frequency of blood transfusion 0.9% 1.2% NS
Incidence of postoperative fever 4.5% 4.7% NS
Mean OR time in minutes (range) 55 (25 – 161) 51 (20 – 107) NS
Mean postpartum stay in days 
(range)
3.6 (2 – 7) 3.4 (2 – 12) NS
Table 4: Incidence of hemorrhage stratified by size of fibroid removed, compared with controls
Size of fibroid (diameter) Myomectomy Control p-value
< 3 cm 4/40 (10%) 7/71 (9.9%) NS
≥ 3 cm and < 6 cm 5/46 (10.9%) 14/97 (14.4%) NS
≥ 6 cm 5/22 (22.7%) 6/45 (13.3%) NS
* Patients were excluded from analysis if the size of the fibroid was not indicated in the operative report, pathology report, or antenatal ultrasound 
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Discussion
The management of fibroids encountered during cesarean
delivery poses a therapeutic dilemma. Myomectomy has
traditionally been discouraged during cesarean delivery.
In fact, many surgeons perform classical cesarean instead
of a low transverse cesarean as a means to avoid lower
uterine segment myomas, a procedure which carries a risk
of increased blood loss in and of itself. The largest series
to date to evaluate this debate, this study helps to allay
some of the fears of increased short-term morbidity with
cesarean myomectomy. In this study, we have demon-
strated that myomectomy performed at time of cesarean
delivery does not increase the risk of hemorrhage, postop-
erative fever, or prolong hospital stay. These results indi-
cate that in selected patients and in experienced hands,
myomectomy during cesarean delivery can be a safe
procedure.
But, in which patients? Clearly, large fundal, intramural
fibroids intuitively should be avoided. Although no statis-
tically significant difference was found between the
patients who underwent intramural myomectomy or
myomectomy of a fibroid greater than 6 cm in diameter
and the control group, this lack of a difference may be
attributed to a small sample size and therefore insufficient
power to detect such a difference. Thus, intramural myo-
mectomy should be performed with caution. But, in the
setting of the symptomatic patient with an accessible sub-
serosal or pedunculated fibroid or the patient with
fibroids obstructing the lower uterine segment, our find-
ings indicate that this procedure can be safely accom-
plished. Several recent studies have described techniques
which can minimize blood loss at cesarean myomectomy,
including uterine tourniquet, [8,9] bilateral uterine artery
ligation, [9] and electrocautery. [10] Although none of
these techniques were used in our study, they may further
reduce blood loss during cesarean myomectomy.
This study has several limitations. Given its retrospective
study design, it is subject to several possible biases,
namely reporting bias and selection bias. When myomec-
tomy was performed, the operative note clearly stated
where the fibroids were located and how the procedure
was performed. It is possible that in patients undergoing
cesarean delivery alone, the incidence of fibroids was
under-reported. Furthermore, as 86% of patients who
underwent myomectomy had no clear indication for the
procedure documented in the operative report, there may
be some degree of selection bias.
Conclusions
Despite these limitations, the message from this study is
clear: what was once thought to be taboo should now be
reconsidered. Myomectomy during cesarean delivery can
be a safe, effective procedure in experienced hands.
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